Methodological considerations in a meta analysis of interferon treatments in relapsing-remitting multiple sclerosis

被引:0
|
作者
Mikol, DD
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S61 / S61
页数:1
相关论文
共 50 条
  • [41] Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
    Cocco, Eleonora
    Marrosu, Maria Giovanna
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 759 - 766
  • [42] Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
    Río, J
    Nos, C
    Tintoré, M
    Téllez, N
    Galán, I
    Pelayo, R
    Comabella, M
    Montalban, X
    [J]. ANNALS OF NEUROLOGY, 2006, 59 (02) : 344 - 352
  • [43] The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments
    Kieseier, Bernd C.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (01) : 105 - 120
  • [44] Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
    Lugaresi, Alessandra
    di Ioia, Maria
    Travaglini, Daniela
    Pietrolongo, Erika
    Pucci, Eugenio
    Onofrj, Marco
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 893 - 914
  • [45] Systematic literature review and network meta-analysis of Ozanimod compared with other treatments in relapsing-remitting multiple sclerosis
    Tencer, T.
    Snedecor, S. J.
    Nicoloso, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 574 - 574
  • [46] Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis
    Sorensen, PS
    Fazekas, F
    Lee, M
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (06) : 557 - 563
  • [47] IMMUNOMODULATORS AND IMMUNOSUPPRESSANTS FOR PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS: A NETWORK META-ANALYSIS
    Lucchetta, R. C.
    Tonin, F. S.
    Borba, H. H.
    Leonart, L. P.
    Ferreira, V. L.
    Bonetti, A. F.
    Riveros, B. S.
    Becker, J.
    Pontarolo, R.
    Fernandez-Llimos, F.
    Wiens, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S203 - S204
  • [48] Impact of beta-interferon on disability progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, K.
    Walsh, C.
    Hutchinson, M.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 102 - 103
  • [49] A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis - Reply from the authors
    Koch-Henriksen, Nils
    Sorensen, Per Soelberg
    [J]. NEUROLOGY, 2006, 67 (12) : 2264 - 2265
  • [50] Subtypes of Relapsing-Remitting Multiple Sclerosis Identified by Network Analysis
    Howlett-Prieto, Quentin
    Oommen, Chelsea
    Carrithers, Michael
    Hier, Daniel
    [J]. NEUROLOGY, 2023, 100 (17)